Search results for "caffold"

showing 10 items of 470 documents

Physico-chemical and mechanical characterization of in-situ forming xyloglucan gels incorporating a growth factor to promote cartilage reconstruction

2016

Abstract The development of growth factors is very promising in the field of tissue regeneration but specifically designed formulations have to be developed in order to enable such new biological entities (NBEs). In particular, the range of therapeutic concentrations is usually very low compared to other active proteins and the confinement in the target site can be of crucial importance. In-situ forming scaffolds are very promising solutions for minimally invasive intervention in cartilage reconstruction and targeting of NBEs. In this work injectable, in-situ forming gels of a temperature responsive partially degalactosylated xyloglucan (Deg-XG) incorporating the growth factor FGF-18 are fo…

In situInjectionFibroblast Growth FactorChemical Phenomenamedicine.medical_treatment02 engineering and technologyFibroblast growth factor01 natural sciencesViscositychemistry.chemical_compoundTissue ScaffoldSettore BIO/10 - BiochimicaComposite materialGlucansGelTissue ScaffoldsIn-situ forming gelsViscosityGrowth factor021001 nanoscience & nanotechnologyGlucanXyloglucanmedicine.anatomical_structureSettore ING-IND/22 - Scienza E Tecnologia Dei MaterialiMechanics of MaterialsXylansMaterials Science (all)0210 nano-technologyMaterials scienceMechanical PhenomenaInjectable scaffoldsBioengineeringCondensed Matter Physic010402 general chemistryInjectable scaffoldInjectionsBiomaterialsShear modulusXylanChondrocytesmedicineAnimalsMechanics of MaterialXyloglucanCartilage reconstructionCell ProliferationMechanical PhenomenaAnimalCartilageGrowth factorMechanical EngineeringIn-situ forming gelChondrocyte0104 chemical sciencesFibroblast Growth FactorsMolecular WeightCartilagechemistryBiophysicsCattleSettore CHIM/07 - Fondamenti Chimici Delle TecnologieTemperature-responsiveGels
researchProduct

Boosting the in situ encapsulation of proteins with MIL-100(Fe): the role of strong Lewis acid centers

2021

Encapsulation of biomolecules using Metal-Organic Frameworks (MOFs) to form stable biocomposites has been demonstrated a valuable strategy for their preservation and controlled release, which has been however restricted to specific electrostatic surface conditions. We present a general in situ strategy that promotes the spontaneous MOF growth onto a broad variety of proteins, for the first time, regardless of their surface nature. We demonstrate that MOFs based on cations exhibiting considerable inherent acidity such as MIL-100(Fe) enable biomolecule encapsulation, including alkaline proteins previously inaccesible by the welldeveloped in situ encapsulation with azolate-based MOFs. In parti…

In situchemistry.chemical_classificationScaffoldchemistryBiomoleculefungiTriggered releaseNanotechnologyBiocompatible materialControlled releaseSurface conditionsEncapsulation (networking)
researchProduct

Construction of Spirooxindole Analogues Engrafted with Indole and Pyrazole Scaffolds as Acetylcholinesterase Inhibitors

2021

Twenty-five new hits of spirooxindole analogs 8a–y engrafted with indole and pyrazole scaffolds were designed and constructed via a [3+2]cycloaddition (32CA) reaction starting from three components: new chalcone-based indole and pyrazole scaffolds 5a–d, substituted isatins 6a–c, and secondary amines 7a–d. The potency of the compounds were assessed in modulating cholinesterase (AChE) activity using Ellman’s method. Compounds 8i and 8y showed the strongest acetylcholine esterase inhibition (AChEI) with IC50 values of 24.1 and 27.8 μM, respectively. Molecular docking was used to study their interaction with the active site of hAChE. peerReviewed

Indole testChemistryStereochemistrybioaktiiviset yhdisteetGeneral Chemical EngineeringGeneral ChemistryPyrazoleindolespeptides and proteinsAcetylcholinesterasemolecular mechanicsArticleinhibitionchemistry.chemical_compoundChemistryscaffoldsQD1-999orgaaniset yhdisteetinhibiittorit
researchProduct

Development of an lbuprofen-Releasing Biodegradable PLA/PGA Electrospun Scaffold for Tissue Regeneration

2009

Our aim was to develop a biodegradable fibrous dressing to act as a tissue guide for in situ wound repair while releasing Ibuprofen to reduce inflammation in wounds and reduce pain for patients on dressing changes. Dissolving the acid form of Ibuprofen (from 1% to 10% by weight) in the same solvent as 75% polylactide, 25% polyglycolide (PLGA) polymers gave uniformly loaded electrospun fibers which gave rapid release of drug within the first 8 h and then slower release over several days. Scaffolds with 10% Ibuprofen degraded within 6 days. The Ibuprofen released from these scaffolds significantly reduced the response of fibroblasts to major pro-inflammatory stimulators. Fibroblast attachment…

KeratinocytesScaffoldPolyglycolidePolyesterswound healingBioengineeringBiocompatible MaterialsIbuprofenbiodegradationApplied Microbiology and Biotechnologychemistry.chemical_compoundTissue engineeringmedicineCell AdhesionHumansdrug releaseCells CulturedCell ProliferationTissue EngineeringTissue ScaffoldsChemistryorganic chemicalsRegeneration (biology)Anti-Inflammatory Agents Non-SteroidalFibroblastsIbuprofenPLGAinflammationSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDelayed-Action PreparationsLiberationWound healingPolyglycolic AcidBiotechnologyBiomedical engineeringmedicine.drug
researchProduct

In vitro and in vivo characterization of porcine acellular dermal matrix for gingival augmentation procedures

2013

Recently, porcine acellular dermal matrix (PADM) has been proposed as a possible alternative to autogenous grafts in periodontal plastic surgery. The aim of the present study was to investigate the in vitro responses of four different oral cell lines cultured on a novel PADM. Furthermore, tissue reaction to PADM was evaluated histologically after subcutaneous implantation in mice.Human gingival fibroblasts (HGF), human osteoblast-like cells, human umbilical vein endothelial cells and human oral keratinocytes (HOK) were cultured and transferred on to the PADM. A tissue culture polystyrene surface served as the control. The viability of all tested cell lines on PADM was measured by using the …

Keratinocytesmedicine.medical_specialtyTime FactorsCell SurvivalCell TransplantationSwineCell Culture TechniquesGingivaMice NudeTetrazolium SaltsAdenylate kinaseUmbilical veinCell LineAndrologyMiceSubcutaneous TissueIn vivoHuman Umbilical Vein Endothelial CellsmedicineAnimalsHumansCytotoxic T cellAcellular DermisColoring AgentsGingivoplastyOsteoblastsTissue EngineeringTissue ScaffoldsAugmentation procedureChemistryAdenylate KinaseSoft tissueFibroblastsIn vitroSurgeryThiazolesCell cultureGuided Tissue Regeneration PeriodontalPeriodonticsColorimetryFemaleIndicators and ReagentsJournal of Periodontal Research
researchProduct

Biomimetic Alginate/Gelatin Cross-Linked Hydrogels Supplemented with Polyphosphate for Wound Healing Applications

2020

In the present study, the fabrication of a biomimetic wound dressing that mimics the extracellular matrix, consisting of a hydrogel matrix composed of non-oxidized and periodate-oxidized marine alginate, was prepared to which gelatin was bound via Schiff base formation. Into this alginate/oxidized-alginate-gelatin hydrogel, polyP was stably but reversibly integrated by ionic cross-linking with Zn2+ ions. Thereby, a soft hybrid material is obtained, consisting of a more rigid alginate scaffold and porous structures formed by the oxidized-alginate-gelatin hydrogel with ionically cross-linked polyP. Two forms of the Zn-polyP-containing matrices were obtained based on the property of polyP to f…

Keratinocyteszinc ionscell migrationMetal NanoparticlesPharmaceutical ScienceBiocompatible Materials02 engineering and technologyGelatinAnalytical ChemistryExtracellular matrixchemistry.chemical_compoundBiomimeticsCell MovementPolyphosphatesSpectroscopy Fourier Transform InfraredDrug DiscoveryalginateSkinchemistry.chemical_classificationcoacervate0303 health sciencesCoacervateTissue ScaffoldsHydrogelsPolymerHydrogen-Ion Concentration021001 nanoscience & nanotechnologyExtracellular MatrixZincChemistry (miscellaneous)Self-healing hydrogelsMolecular Medicine0210 nano-technologyHybrid materialPorosityinorganic polyphosphatefood.ingredientionic cross-linkingAlginatesCell Survivalperiodate oxidationArticlegelatinlcsh:QD241-44103 medical and health sciencesfoodlcsh:Organic chemistryHumansPhysical and Theoretical Chemistry030304 developmental biologyIonsWound HealingTissue EngineeringPolyphosphateOrganic Chemistryhuman epidermal keratinocytestechnology industry and agricultureChemical engineeringchemistrynanoparticlesEpidermisWound healingMolecules
researchProduct

Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry.

2016

Aims: We aimed to investigate the outcomes of bioresorbable vascular scaffolds (BVS) in coronary ostial lesions. Ostial lesions represent a challenging angiographic subset, with higher event rates compared with non-ostial lesions. BVS might be associated with advantages over the long term, but their safety in this setting remains to be explored. Methods and results: Procedural and 12-month follow-up data from consecutive patients treated with BVS for lesions located at the ostium of the right (RCA), left anterior (LAD) or circumflex (LCX) coronary in 11 European centres were collected. The primary device-oriented endpoint was defined as a combination of cardiovascular death, target vessel m…

LCX (29Target lesionMale52%). Patients presenting with ostial lesions did not differ from the remaining cohort except for a higher incidence of prior revascularisation. Predilation was performed in 97% of the lesions (vs. 96% in non-ostialp= 0.035)medicine.medical_treatmentMyocardial Infarction304 patients with a mean age of 62 +/- 11years. There were 90 ostial lesions (5.8%) in 84 patients (6.4%) located at the ostial RCA (14Coronary Artery Disease030204 cardiovascular system & hematologyCoronary artery diseasebut their safety in this setting remains to be explored. Methods and results: Procedural and 12-month follow-up data from consecutive patients treated with BVS for lesions located at the ostium of the right (RCA)0302 clinical medicineAbsorbable Implants030212 general & internal medicineMyocardial infarctionCircumflexRegistriesTissue Scaffolds32%)Drug-Eluting StentsMiddle AgedThrombosisCoronary VesselsAims: We aimed to investigate the outcomes of bioresorbable vascular scaffolds (BVS) in coronary ostial lesions. Ostial lesions represent a challenging angiographic subset with higher event rates compared with non-ostial lesions. BVS might be associated with advantages over the long term but their safety in this setting remains to be explored. Methods and results: Procedural and 12-month follow-up data from consecutive patients treated with BVS for lesions located at the ostium of the right (RCA) left anterior (LAD) or circumflex (LCX) coronary in 11 European centres were collected. The primary device-oriented endpoint was defined as a combination of cardiovascular death target vessel myocardial infarction or target lesion revascularisation. The database included a total of 1549 lesions in 1304 patients with a mean age of 62 +/- 11years. There were 90 ostial lesions (5.8%) in 84 patients (6.4%) located at the ostial RCA (14; 16%) LCX (29; 32%) or LAD (47; 52%). Patients presenting with ostial lesions did not differ from the remaining cohort except for a higher incidence of prior revascularisation. Predilation was performed in 97% of the lesions (vs. 96% in non-ostial p= 0.618) post-dilation in 43% (versus 58% in the non-ostial group p= 0.008). At quantitative coronary angiography treatment of ostial lesions was associated with higher residual stenosis (30% [23-41] vs. 26% [20-37] p= 0.035) but no difference in minimum lumen diameter existed (p= 0.447). Follow-up data were available at 385 [362-465] days. The 12-month Kaplan-Meier estimated rates of scaffold thrombosis were 4.9% and 2.0% (ostial and non-ostial lesion groups respectively log-rank p= 0.005). The device-oriented composite endpoint occurred respectively in 12.6% and 4.6% at 12 months (log-rank p= 0.001). Treatment of ostial lesions was an independent predictor of this endpoint (p= 0.0025 HR 2.65 [1.41-4.97]).OstiumAims: We aimed to investigate the outcomes of bioresorbable vascular scaffolds (BVS) in coronary ostial lesions. Ostial lesions represent a challenging angiographic subsetTreatment Outcomein 12.6% and 4.6% at 12 months (log-rank p= 0.001). Treatment of ostial lesions was an independent predictor of this endpoint (p= 0.0025CardiologyFemale549 lesions in 1medicine.symptomCardiology and Cardiovascular MedicineAdultpost-dilation in 43% (versus 58% in the non-ostial groupmedicine.medical_specialtyor LAD (47HR 2.65 [1.41-4.97])but no difference in minimum lumen diameter existed (p= 0.447). Follow-up data were available at 385 [362-465] days. The 12-month Kaplan-Meier estimated rates of scaffold thrombosis were 4.9% and 2.0% (ostial and non-ostial lesion groupsrespectivelyLesion03 medical and health sciencesPercutaneous Coronary Interventionwith higher event rates compared with non-ostial lesions. BVS might be associated with advantages over the long termleft anterior (LAD) or circumflex (LCX) coronary in 11 European centres were collected. The primary device-oriented endpoint was defined as a combination of cardiovascular deathInternal medicinemedicineHumanstarget vessel myocardial infarction or target lesion revascularisation. The database included a total of 1Agedp= 0.008). At quantitative coronary angiographybusiness.industryPercutaneous coronary interventionp= 0.618)treatment of ostial lesions was associated with higher residual stenosis (30% [23-41] vs. 26% [20-37]log-rank p= 0.005). The device-oriented composite endpoint occurredmedicine.diseaseSurgery16%)businessEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
researchProduct

Tuen muodot ja oppimisen mahdollisuudet suomen kielen verkkokurssilla

2013

Tutkimuksessa tarkastellaan ulkomailla suomea opiskeleville suunniteltua A2–B1-tasoista verkkokurssia. Aineistona ovat kurssin osallistujien paivakirjamerkinnat, palautelomakkeet, viestit seka itse kurssi materiaaleineen. Verkkokurssia analysoidaan ekologisessa viitekehyksessa opiskelijoiden kokeman tuen seka affordanssin kasitteiden kautta. Tuloksista kay ilmi, etta kurssilla on runsaasti mahdollisuuksia vastavuoroiseen vertaistukeen. Ohjaajan antamaksi tueksi oppijat mieltavat erityisesti kurssin alussa kielen rakennetta ja sanastoa koskevan palautteen ja niihin liittyvat tehtavat. Affordanssiksi oppijoiden nakokulmasta nousevat sanasto, kielen rakenteeseen liittyvat ilmiot seka kulttuuri…

Linguistics and Languagescaffoldingsuomi toisena ja vieraana kielenälcsh:Finnic. Baltic-Finniclcsh:PH91-98.5verkko-opetusekologinen näkökulmatoimintalähtöinen pedagogiikkaaffordanssiLanguage and LinguisticsLähivõrdlusi. Lähivertailuja
researchProduct

Extracellular Matrix Molecular Remodeling in Human Liver Fibrosis Evolution

2016

Chronic liver damage leads to pathological accumulation of ECM proteins (liver fibrosis). Comprehensive characterization of the human ECM molecular composition is essential for gaining insights into the mechanisms of liver disease. To date, studies of ECM remodeling in human liver diseases have been hampered by the unavailability of purified ECM. Here, we developed a decellularization method to purify ECM scaffolds from human liver tissues. Histological and electron microscopy analyses demonstrated that the ECM scaffolds, devoid of plasma and cellular components, preserved the three-dimensional ECM structure and zonal distribution of ECM components. This method has been then applied on 57 l…

Liver Cirrhosis0301 basic medicineProteomicsPathologyProteomeBiopsylcsh:MedicineHepacivirusMatrix (biology)ProteomicsBiochemistryExtracellular matrixMiceLiver disease0302 clinical medicineFibrosisSettore BIO/13 - Biologia ApplicataMedicine and Health Scienceslcsh:Scienceliver fibrosisExtracellular Matrix ProteinsMultidisciplinaryDecellularizationAnimals; Extracellular Matrix; Hepacivirus; Humans; Liver; Liver Cirrhosis; Mice; Proteome; Proteomics; Tissue Scaffolds; Disease ProgressionTissue ScaffoldsChemistryLiver DiseasesLiver030220 oncology & carcinogenesisProteomeDisease ProgressionCellular Structures and OrganellesAnatomyliver fibrosis; extracellular matrix; proteomicsResearch Articlemedicine.medical_specialtyHistologySettore BIO/06extracellular matrixSurgical and Invasive Medical ProceduresGastroenterology and HepatologyScaffold03 medical and health sciencesmedicineAnimalsHumansHuman liverlcsh:RBiology and Life SciencesProteinsCell Biologymedicine.diseaseFibrosisLiver Fibrosi030104 developmental biologyLiver Fibrosis; Scaffold; Proteomicslcsh:QCollagensDevelopmental Biology
researchProduct

Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts.

2012

A disseminated model of non-Hodgkin's lymphoma with prevalent liver metastasis was generated by intraperitoneal (i.p.) injection of EBV(+) B lymphoblastoid SKW6.4 in nude-SCID mice. The survival of SKW6.4 xenografts (median survival = 27 days) was significantly improved when hyaluronan scaffolds embedded with mesenchimal stem cells (MSC) were implanted in the abdominal area 4 days after SKW6.4 injection (median survival = 39.5 days). Mice implanted with MSC showed a significant improvement of hepatic functionality in lymphoma xenografts, as demonstrated by measurement of serum ALT/AST levels. Co-culture of MSC with lymphoma cells enhanced the release of hepatocyte growth factor (HGF) by MSC…

Liver functionality. Lymphoma-bearing xenograftsPathologymedicine.medical_specialtyTime FactorsCell SurvivalMice NudeCell CommunicationMice SCIDMesenchymal Stem Cell Transplantationlymphoma.Mesenchymal stem cells; hepato-protective; lymphoma.Metastasischemistry.chemical_compoundMicehemic and lymphatic diseasesCell Line Tumorhepato-protectiveHyaluronic acidMedicineAnimalsHumansPharmacology (medical)Aspartate AminotransferasesHyaluronic AcidMesenchymal stem cellPharmacologyMesenchymal stem cells; Liver functionality. Lymphoma-bearing xenograftsTissue Scaffoldsbusiness.industryHepatocyte Growth FactorLymphoblastLymphoma Non-HodgkinMesenchymal stem cellLiver NeoplasmsAlanine TransaminaseMesenchymal Stem Cellsmedicine.diseaseXenograft Model Antitumor AssaysCoculture TechniquesLymphomaOncologychemistryLiverCell cultureHepatocyte growth factorStem cellbusinessBiomarkersmedicine.drugInvestigational new drugs
researchProduct